Scedosporium boydii pulmonary infection in an immunocompetent patient with COPD confirmed by next-generation metagenomic sequencing and culture: a case report
Authors:
Open Access
- 24 July 2025
- journal article
- case report
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-7
Abstract
Scedosporium boydii infections pose diagnostic challenges due to their nonspecific clinical manifestations and slow growth characteristics in conventional cultures. This paper highlights the diagnostic value of molecular technology combined with targeted prolonged culture for rare fungi. Unitl now, only one case was identified using metagenomic next-generation sequencing (mNGS). This case represents the first report of a 20-day delayed culture confirmation of S. boydii guided by mNGS results in a non-immunocompromised chronic obstructive -with history of COPD who was admitted with fever and cough. Despite two weeks of antibacterial treatment, chest computed tomography (CT) showed worsening infection. To clarify the pathogen, mNGS and bacterial culture of bronchoalveolar lavage fluid (BALF) were performed. Subsequent culture and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) confirmed the growth of Scedosporium species. Based on clinical presentation, chest CT findings, mNGS results, pulmonary Scedosporiosis was diagnosed, and an antifungal treatment regimen (200 mg BID orally) was initiated. Subsequent culture confirmed S. boydii growth and antifungal susceptibility results were also obtained. After six weeks of voriconazole treatment, he was discharged from the hospital and continued to take oral medication for three months. He was fully recovered without recurrence after six months of follow-up. The present case suggests that mNGS findings can unveil cryptic pathogens like Scedosporium. Use mNGS results to trigger intentional, extended targeted cultivation– challenging standard incubation times– especially in non-immunocompromised hosts with underlying lung disease. Seamless clinician-laboratory collaboration is paramount for treatment success.Keywords
Funding Information
- Precision Medicine Joint Fund Cultivation Project of the Natural Science Foundation of Hebei Province (H2020206449)
- Open Research Project of Hebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention (YNXJYJKF-001)
- Key Project of the Hebei Provincial Medical Science Research Program (20180460)
- Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine (2024143)
This publication has 23 references indexed in Scilit:
- Pseudallescheria/Scedosporium complex species: From saprobic to pathogenic fungusJournal of Medical Mycology, 2018
- Spontaneous Remission of Subcutaneous Scedosporiosis Caused by Scedosporium dehoogii in a Psoriatic PatientMycopathologia, 2017
- Fungal Planet description sheets: 469-557Persoonia - Molecular Phylogeny and Evolution of Fungi, 2016
- Endophthalmitis of probable endogenous origin caused by Scedosporium boydii: A case reportRevista Iberoamericana de Micologia, 2016
- Susceptibility and Diversity in the Therapy-Refractory Genus ScedosporiumAntimicrobial Agents and Chemotherapy, 2014
- Clinical characteristics and epidemiology of pulmonary pseudallescheriasisRevista Iberoamericana de Micologia, 2012
- Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 PatientsAntimicrobial Agents and Chemotherapy, 2008
- Molecular and Phenotypic Data Supporting Distinct Species Statuses for Scedosporium apiospermum and Pseudallescheria boydii and the Proposed New Species Scedosporium dehoogiiJournal of Clinical Microbiology, 2008
- Scedosporiosis in patients with acute leukemia: a retrospective multicenter reportHaematologica, 2008
- Pseudallescheria boydii or Aspergillus fumigatus in a lady with an unresolving lung infiltrate, and a literature reviewRespirology, 2007